Illumina Ventures

What’s the potential impact of DELFI Diagnostics' cancer detection tests on healthcare? DELFI’s dynamic CEO Susan Tousi answers that question in this month’s Illumina Ventures CEO Spotlight. Susan discusses the unique population that can benefit from DELFI’s cancer detection test, the opportunities that lie ahead, and why the investment from Illumina Ventures is so important. Visit the website to hear more from our conversation: https://lnkd.in/eFcb4yCP

Congratulations to DELFI Diagnostics on their collaboration with Florida Lung Health Coalition, RadNet, and the American Lung Association to launch a new lung cancer screening and detection initiative in Florida. This November for #LungCancer Awareness Month, eligible patients can access the FirstLook Lung test—a simple blood test to identify at-risk individuals. Elevated results will prompt a low-dose CT scan, boosting early detection rates in Florida, where only 15.8% are currently screened. Learn more: https://lnkd.in/gKMhEzGW #PartnerNews

Last week, our Partner Mara Aspinall had the privilege of moderating two insightful panels at the ASU Annual Diagnostics Summit in Arizona. The event brought together 200 people from industry and academia to explore the most exciting innovations as well as pressing challenges in #diagnostics. Mara is pictured here with two fellow moderators, Michael Donovan, PhD, JD, (left) and Travis Schlappi, PhD, (right), both Assistant Teaching Professors in the ASU College of Health Solutions. A big thank you to the College of Health Solutions for facilitating such meaningful conversations!  

Attovia Therapeutics, a #biopharma company shaping the future of #immunology and #inflammation, has appointed Steven Chan as Chief Financial Officer. Steven will oversee the company’s finance and operations functions and contribute to its strategic growth.    “I am delighted to welcome Steve to Attovia at this critical growth period for the company. He brings over thirty years of financial leadership and expertise spanning biotechnology, healthcare, technology, consumer products, and beyond,” said Tao Fu, Attovia Chief Executive Officer. “Steve’s track record of success across private-stage, private-to-public transitions, and public-stage companies is invaluable to Attovia’s expansion and overall corporate strategy.”    More details: https://lnkd.in/gXVFwfti    #PartnerNews 

Illumina Ventures Partner Mara Aspinall will host and moderate two key panels at the upcoming ASU Annual Diagnostics Summit hosted by the ASU College of Health Solutions. The summit convenes leaders from academia, industry, and government to discuss, debate, and decide the most relevant issues in #diagnostics.      📅 Date: Thursday, October 17, 2024  ⏰ Time: 8am - 1pm PT  📍 Health Futures Center, Phoenix, AZ (In-person & Virtual)     Featured Panels:     ✨ Panel 1 | Smart Integration: Diagnostics, Drugs, Devices, and Data  ✨ Lunch Panel | Leading Diagnostics Companies at a Turbulent Time    Register here: https://lnkd.in/gbK8U3eU 

Our Partner Mara Aspinall recently shared her insights with the Arizona Daily Star regarding the underfunding of women entrepreneurs in connection with the new documentary, Show Her The Money. 🎬     Mara highlighted the significant gap in venture capital for women-owned businesses and the need for change in the industry. Learn more about the conversation and the film here. https://lnkd.in/gYMk6x9d 

DELFI Diagnostics, a leader in next-generation blood-based #CancerDetection, has partnered with Allegheny Health Network (AHN) to evaluate the effectiveness of DELFI’s FirstLook blood test for #LungCancer screening. Using advanced whole-genome #MachineLearning, FirstLook analyzes cell-free DNA to help identify individuals at risk for lung cancer—the leading cause of cancer-related deaths worldwide.     With a 99.8% negative predictive value, the test offers a more accessible way to improve early detection and patient outcomes. Learn more: https://lnkd.in/gSUCSyiX    #PartnerNews 

Congratulations to Integrated Biosciences, Inc.. on raising $17.2M in #SeedFunding to accelerate the development of its drug pipeline, further advance its technology platform, and ramp up its commercialization efforts.    As a pioneering #biotech company, Integrated Biosciences combines #SyntheticBiology and #AI-driven small-molecule #DrugDiscovery to develop next-gen #therapeutics for age-related diseases.     Illumina Ventures Labs is proud to support this innovative team as they push the boundaries of drug discovery! 👏    Read more in GenomeWeb: https://lnkd.in/gFgiXgww

Congratulations to LetsGetChecked, a leading global #healthcare solutions company, on its acquisition of digital pharmacy platform, Truepill. The acquisition strengthens LetsGetChecked’s ability to help healthcare partners deliver the best quality of care and improve health outcomes across their populations.    Learn more: https://lnkd.in/eEcdNPf4    #PartnerNews 

🎉 Congratulations to Iambic Therapeutics on being named to Endpoints News’ 11 Most Promising Biotech Startups! Iambic’s groundbreaking work with its #AI-driven discovery platform has led to rapid advancements in novel #therapeutics, including a clinical-stage lead program. 🚀 This recognition underscores Iambic’s transformative impact on #DrugDiscovery, and we’re excited to see their continued innovations in #oncology and beyond. 🌟    Read more: https://lnkd.in/gMuC8s67